TRVN: Trevena, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.98
Enterprise Value ($M) 4.81
Book Value ($M) -7.66
Book Value / Share -0.42
Price / Book -0.91
NCAV ($M) -13.06
NCAV / Share -0.71
Price / NCAV -0.53

Profitability (mra)
Return on Invested Capital (ROIC) -1.41
Return on Assets (ROA) -1.05
Return on Equity (ROE) -3.97

Liquidity (mrq)
Quick Ratio 4.66
Current Ratio 4.66

Balance Sheet (mrq) ($M)
Current Assets 35.20
Assets 40.60
Liabilities 48.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.12
Operating Income -35.29
Net Income -40.29
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.03
Cash from Investing -0.04
Cash from Financing 26.31

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 132.87

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-14 10-Q f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-15 10-Q f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 26,891 113,055 23.79
2024-04-24 9,924 4,010 247.48
2024-04-23 64,969 13,156 493.84
2024-04-22 76,169 44,652 170.58

(click for more detail)

Similar Companies
TNXP – Tonix Pharmaceuticals Holding Corp. TPST – Tempest Therapeutics, Inc.
TRAW – Traws Pharma, Inc. TTNP – Titan Pharmaceuticals, Inc.
UNCY – Unicycive Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Trevena